UK health manager permits using Pfizer/BioNTech COVID inoculation for children
(MENAFN) Britain’s health manager on Tuesday gave the green light to the use of a Pfizer/BioNTech coronavirus inoculation for babies and children aged six months to 4 years.
According to the declaration, the Medicines and Healthcare Products Regulatory Agency (MHRA) made an announcement that the Comirnaty COVID inoculation has achieved its essential safety, quality and effectiveness standards.
"This presentation is specially designed for this new age group and given at a lower dose compared to that used in individuals aged 5 to 11 years (3 micrograms compared with 10 micrograms)," in agreement with MHRA.
It added that before the decision, the agency studied data from a current clinical trial involving 4,526 participants and said that likely side effects “were in-keeping with what can be anticipated from a vaccine in this age group.”
"It is given as three injections in the upper arm, with the first two doses given 3 weeks apart, followed by a third dose given at least 8 weeks after the second dose," the statement also read.
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.